{
  "docId": "019de075-d132-769f-97bd-4a840dd24899",
  "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 54,
  "pageCount": 56,
  "prevPage": 53,
  "nextPage": 55,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The central graphic is an antibody structure inside a pentagon, representing the five optimization pillars.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/54",
  "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
  "deckJsonHref": "/decks/019de075-d132-769f-97bd-4a840dd24899.json",
  "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-54",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.1,
        "x": 0.545,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Potency curve",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2bca150a-15ae-4d41-bdb6-be6adc373074",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.5,
        "x": 0.25,
        "y": 0.2
      },
      "kind": "framework",
      "text": "Five-pillar optimization framework",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d33a718e-1dc6-4179-8e2b-be277391408d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "1. Potency: Targeting the best epitope and maximizing in vitro responses\n2. Safety: Target specificity and low immunogenicity\n3. Manufacturability: Plug-and-play manufacturing and highly stable\n4. Formulatability: More drug and less pain\n5. Pharmacokinetics: Longer half-life for fewer shots",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e5a02288-64b5-4004-98d4-d9f107b869ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.02,
        "y": 0.03
      },
      "kind": "title",
      "text": "Paragon aims to engineer best-in-class antibodies by optimizing across five key properties",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c3b2f05a-ee7b-4ff5-83af-2d184dca6376",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "210e15bc-7c58-4967-b2b4-3521e5fb8f10",
      "evidence": "framework/instance: Five-pillar optimization framework",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "pentagon-optimization-model",
      "slug": null,
      "matchId": "9bcf1a98-ab22-448c-9963-864f73bc4a51",
      "evidence": "Visual pentagon structure used to categorize five distinct engineering properties.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 56,
      "from": 45,
      "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}